Pharmacokinetic study of two extended-release formulations of cilostazol in healthy Korean subjects: A randomized, open-label, multiple-dose, two-period crossover study  .

CONCLUSION: Cilostazol SR showed significantly higher Cmax,ss and AUCτ of cilostazol than cilostazol CR after 5 days of multiple dosing of extended-release formulations of cilostazol. . PMID: 31079600 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31079600?dopt=Abstract

Source: International Journal of Clinical Pharmacology and Therapeutics - May 14, 2019 Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research

More News: Cilostazol | Drugs & Pharmacology | Headache | Migraine | Study

Pharmacokinetic study of two extended-release formulations of cilostazol in healthy Korean subjects: A randomized, open-label, multiple-dose, two-period crossover study .

Pharmacokinetic study of two extended-release formulations of cilostazol in healthy Korean subjects: A randomized, open-label, multiple-dose, two-period crossover study  .